Department of Laboratory Medicine, Gangnam Severance Hospital, Yonsei University College of Medicine, 211 Eonju-ro, Gangnam-gu, Seoul, 06273, South Korea.
Research Institute of Bacterial Resistance, Yonsei University College of Medicine, Seoul, South Korea.
Sci Rep. 2023 Nov 27;13(1):20777. doi: 10.1038/s41598-023-48194-2.
The COVID-19 pandemic in Korea has dynamically changed with the occurrence of more easily transmissible variants. A rapid and reliable diagnostic tool for detection of SARS-CoV-2 is needed. While RT-PCR is currently the gold standard for detecting SARS-CoV-2, the procedure is time-consuming and requires expert technicians. The rapid antigen detection test (RADT) was approved as a confirmatory test on 14 March 2022 due to rapid dissemination of the Omicron variant. The benefits of the RADT are speed, simplicity, and point-of-care feasibility. The aim of our study was to evaluate the clinical performance of RADT compared to RT-PCR in a single center over 15 months, fully covering the SARS-CoV-2 'Variants of Concern (VOC).' A total of 14,194 cases was simultaneously tested by RT-PCR and RADT from January 2021 to March 2022 in Gangnam Severance Hospital and were retrospectively reviewed. PowerChek SARS-CoV-2, Influenza A&B Multiplex Real-time PCR Kit, and STANDARD Q COVID-19 Ag Test were used. Positive rates, sensitivities, specificities, positive predictive values (PPV), and negative predictive values (NPV) were estimated for five periods (3 months/period). Receiver operator characteristic curve (ROC) analysis was performed, and Spearman's rank test assessed the correlation between RT-PCR Ct values and semi-quantitative RADT results. The overall positive rate of RT-PCR was 4.64%. The overall sensitivity and specificity were 0.577 [95% confidence interval (CI) 0.539-0.614] and 0.991 [95% CI 0.989-0.993], respectively. ROC analysis resulted in an area under the curve of 0.786 (P < 0.0001, Yuden's index = 0.568). The PCR positive rates were estimated as 0.11%, 0.71%, 4.51%, 2.02%, and 13.72%, and PPV was estimated as 0.045, 0.421, 0.951, 0.720, and 0.798 in Periods 1, 2, 3, 4, and 5, respectively. A significant and moderate negative correlation between PCR Ct values and semi-quantitative RADT results was observed (Spearman's ρ = - 0.646, P < 0.0001). The RADT exhibited good performance in specimens with low Ct values (Ct ≤ 25.00) by RT-PCR. The PPV was significantly higher in Periods 3 and 5, which corresponds to rapid dissemination of the Delta and Omicron variants. The high PPV implies that individuals with a positive RADT result are very likely infected with SARS-CoV-2 and would require prompt quarantine rather than additional RT-PCR testing. The sensitivity of 0.577 indicates that RADT should not replace RT-PCR. Nonetheless, given the high PPV and the ability to track infected persons through rapid results, our findings suggest that RADT could play a significant role in control strategies for further SARS-CoV-2 variants.
韩国的 COVID-19 疫情随着更容易传播的变异株的出现而发生了动态变化。需要一种快速可靠的 SARS-CoV-2 检测诊断工具。虽然 RT-PCR 目前是检测 SARS-CoV-2 的金标准,但该程序耗时且需要专家技术人员。由于奥密克戎变异株的迅速传播,快速抗原检测(RADT)于 2022 年 3 月 14 日被批准作为确认检测。RADT 的优点是速度快、操作简单、适合现场检测。我们的研究目的是在一个 15 个月的时间内,在一个单一的中心评估 RADT 与 RT-PCR 的临床性能,完全覆盖 SARS-CoV-2“关注的变异株(VOC)”。2021 年 1 月至 2022 年 3 月,江南塞弗伦斯医院同时对 14194 例病例进行了 RT-PCR 和 RADT 检测,并进行了回顾性分析。使用了 PowerChek SARS-CoV-2、Influenza A&B Multiplex Real-time PCR Kit 和 STANDARD Q COVID-19 Ag Test。对五个时期(每三个月为一个时期)估计了阳性率、灵敏度、特异性、阳性预测值(PPV)和阴性预测值(NPV)。进行了接收器工作特征曲线(ROC)分析,并使用 Spearman 秩检验评估了 RT-PCR Ct 值和半定量 RADT 结果之间的相关性。RT-PCR 的总体阳性率为 4.64%。总体灵敏度和特异性分别为 0.577(95%置信区间 0.539-0.614)和 0.991(95%置信区间 0.989-0.993)。ROC 分析得出曲线下面积为 0.786(P<0.0001,Yuden 指数=0.568)。PCR 阳性率估计分别为 0.11%、0.71%、4.51%、2.02%和 13.72%,PPV 估计分别为 0.045、0.421、0.951、0.720 和 0.798,在第 1、2、3、4 和 5 期。PCR Ct 值和半定量 RADT 结果之间存在显著且中度的负相关(Spearman ρ=-0.646,P<0.0001)。RADT 在 RT-PCR 的低 Ct 值(Ct≤25.00)标本中表现出良好的性能。第 3 和第 5 期的 PPV 明显更高,这对应于德尔塔和奥密克戎变异株的迅速传播。高 PPV 意味着 RADT 阳性结果的个体很可能感染了 SARS-CoV-2,需要立即隔离,而不是进行额外的 RT-PCR 检测。灵敏度为 0.577 表明 RADT 不应替代 RT-PCR。尽管如此,鉴于高 PPV 和通过快速结果追踪感染人员的能力,我们的研究结果表明,RADT 在进一步的 SARS-CoV-2 变异株控制策略中可能发挥重要作用。